1st TP should be at 0.48, however I think still need to monitor the price movement next week, if it cannot sustain above 0.40, then it could mean the trend is gone.
even it break 0.40 also no need to worry, be confident with it ! am pretty sure this company will up up up because their company will earn more in futures.. very bright prospect .. will buy more if drop..
Let see if the power of pennant able to form up and break up new highest. Many confident shareholders willing to buy more if drop, I am one of them too.
The thing is, if everybody wait for it to drop.... will it drop? Maybe they just miss the bus... The good thing is, they will form very strong support :)
Posted by duitKWSPkita > Feb 5, 2015 02:48 PM | Report Abuse X
thanks for ur support Mr. ppginvest.
every time you masuk duit for HOVID, no need tunggu gaji and beli till duit habis this time. HOVID will starts to give you money after next week........ Do not tambah anymore until you see BIG VOLUME to break RM0.480. AFter RM0.480 it is nt hard to challenge the next target at RM0.530.
waitttttttttttttttt. just support no need to top up. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Dear duitKWSPkita, thank you for the 6.75% dividend :) Today I cannot tahan, got the salary, tambah lagi at 0.42...
Hovid after breakaway from reversal head and shoulder, it was consolidated for 3 days and formed a pennat, this pennant pattern is typical bullish accumulation for the next move and breakaway from immediate resistance RM0.424 to 0.440/0.465/0.480
Resistance is at rm0.48 followed by rm0.53. Support is at rm0.370.
Malaysia’s largest exported of generic drugs, has been increasing its manufacturing capacity to keep up with export demand after venturing into new markets in African and the Middle East. With a presence in nearly 50 countries, the group’s export driven strategy capitalizes on the rising healthcare expenditure in developing countries.
Hovid is aggressively ramping up its export driven strategy to grow its revenue base.
Currently (Dec 2014), exports stands at 52.5% of revenue.
Another continuing theme for the company is the patent cliff phenomenon. Many of the world’s top selling innovator drugs, which constituted as much as USD34 billion in sales in 2012, will go off patent in the next few years from 2014.
The impending expiration of these patents will then pave the way for generic drugmakers such as Hovid to manufacture cheaper variants, which have a ready market among the developing as well as third world countries. During FY2013, the group added 19 new products to its pipeline, which include eight new ethical drugs for prescription purposes.
Hovid does have a boost from the government in capitalizing on the patent cliff. The enhancement of generic drug manufacturing capacity is one of the EPP under the Pemandu ETP.
It is worth nothing that Pemandu had accorded EPP status on Hovid’s agreement with a subsidiary of global pharmaceutical giant Sanofi-Aventis SA Pty Ltd to develop new generic drugs in 2011.
The company is positioned to take advantage of the rising demand for generic products as numerous patents expire in the next five years from 2014.
On the other hand, apart from creating new generic variants of innovator drugs via R&D, Hovid currently (Dec 2014) has an extensive backlog of existing drugs that are awaiting regulatory approval in numerous countries which should come in by end of 2014.
The drugs estimated at 363 types, are currently (Dec 2014) pending product registrations. These drugs are expected to generate rm30 million in sales within 18 months of being officially registered in the respective countries.
Domestically, while originator drug sales currently (Dec 2014) account for half of total drug sales in Malaysia, the increasing shift towards generic drugs may happen in the near future due to escalating costs.
This shift could spur Hovid’s drug sales domestically. In FY2013, 47.5% of Hovid’s revenue came from domestic sales.
It is said to be a healthcare proxy compared with private hospital operators.
It is liked for its exposure to the export markets which an even bigger growth potential than Malaysia.
can I subscribe your update? I see you very very geng although I m bit lost when reading ur article..... as long as ur stock up...who care how terribly competent of u rite??
well done.... great job... pls update us more n more regarding good stock.........
we invest at our own risk... never blame anyone....
mwong3, I also want to subscribe your update eh, cheers !!!!
" Posted by duitKWSPkita > Feb 9, 2015 10:56 AM | Report Abuse
very geng oh you mwong3.................
can I subscribe your update? I see you very very geng although I m bit lost when reading ur article..... as long as ur stock up...who care how terribly competent of u rite??
well done.... great job... pls update us more n more regarding good stock.........
we invest at our own risk... never blame anyone.... "
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DreamEmperor
3,340 posts
Posted by DreamEmperor > 2015-02-07 12:43 | Report Abuse
Any good TP?